New Jersey A1821 prohibits health insurance carriers from denying coverage of nonopioid prescription drugs in favor of opioid prescription drugs.

New Jersey A1821 prohibits health insurance carriers from denying coverage of nonopioid prescription drugs in favor of opioid prescription drugs. The bill also mandates that health insurance carriers ensure nonopioid drugs are not disadvantaged or discouraged in terms of coverage or cost-sharing compared to opioid drugs. This applies to all contracts purchased by the State Health Benefits Commission and the School Employees’ Health Benefits Commission, as well as to Medicaid coverage.

New Jersey A1821 prohibits health insurance carriers from denying coverage of nonopioid prescription drugs in favor of opioid prescription drugs.

New Jersey A1821 prohibits health insurance carriers from denying coverage of nonopioid prescription drugs in favor of opioid prescription drugs. The bill also mandates that health insurance carriers ensure nonopioid drugs are not disadvantaged or discouraged in terms of coverage or cost-sharing compared to opioid drugs. This applies to all contracts purchased by the State Health Benefits Commission and the School Employees’ Health Benefits Commission, as well as to Medicaid coverage.